MVX-ONCO-1 phase 1 final results of the first personalized cell-based immunotherapy using cell encapsulation technology

被引：10
|
作者：
Mach, N. [1 ]
Vernet, R. [1 ]
Belkouch, M-C. [1 ]
Luy, P. [1 ]
Ancrenaz, V. [1 ]
Teta, P. [1 ]
Blazek, N. [1 ]
Grandjean, N. [1 ]
Wasem, J. [1 ]
Grogg, J. [2 ]
Perez, T. [2 ]
Migliorini, D. [1 ]
机构：
[1] HUG, Oncol, Geneva, Switzerland
[2] MaxiVAX SA, Clin Operat, Geneva, Switzerland
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw378.12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1058P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MVX-ONCO-1: First in man, Phase I clinical trial combining encapsulation cell technology and irradiated autologous tumor cells for personalized cell-based immunotherapy. Safety, feasibility and clinical outcome results
    Migliorini, D.
    Vernet, R.
    Belkouch, M. C.
    Luy, P.
    Blaser, S.
    Ancrenaz, V.
    Blazek, N.
    Grandjean, N.
    Wasem, J.
    Janin, B.
    Harboe-Schmidt, P.
    Grogg, J.
    Bouche, N.
    Mach, N.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S114 - S114
  • [2] A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors
    Vernet, Remi
    Fernandez, Eugenio
    Migliorini, Denis
    Ancrenaz, Virginie
    Charrier, Emily
    Belkouch, Marie-Claude
    Von Rohr, Olivier
    Urwyler, Muriel
    De Vito, Claudio
    Renaux, Jessica
    Villard, Jean
    Rubin, Olivier
    Grogg, Julien
    Mach, Nicolas
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (08): : 2089 - 2100
  • [3] Personalized Immunotherapy with Cell-Encapsulation Technology for 2nd line R/M HNSCC: Safety and Early Efficacy Data from all HNSCC patients treated with MVX-ONCO-1 in two clinical trials
    Fernandez, Eugenio
    Vernet, Remi
    Charrier, Emily
    Joerger, Markus
    Belkouch, Marie-Claude
    Urwyler, Muriel
    von Rohr, Olivier
    Rubin, Olivier
    Villard, Jean
    Ancrenaz, Virginie
    Grandjean, Nicole
    Lavalliere, Emmanuel
    Lafferma, Elisabeth
    Grogg, Julien
    Mach, Nicolas
    ORAL ONCOLOGY, 2021, 118
  • [4] SAKK 11/16, a phase IIa trial evaluating overall survival (OS) for recurrent/metastatic Head & neck squamous cell carcinoma (RMHNSCC) patients (pts) progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy
    Mach, N.
    Fernandez, E.
    Vernet, R.
    Vonrohr, O.
    Urwyler, M.
    Charrier, E.
    Belkouch, M. C.
    Saingier, V.
    Courtout, F.
    De Vito, C.
    Rubin, O.
    Ancrenaz, V.
    Grogg, J. N.
    Renaux, J.
    Gysel, K.
    Mueller, G.
    Brezina, T.
    Rordorf, T.
    Joerger, M.
    Michielin, O. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1286 - S1286
  • [5] Cell-based immunotherapy combining encapsulation cell technology and irradiated autologous tumor cells: A novel technology platform that is both safe and feasible. Results from first in man trial
    Mach, N.
    Migliorini, D.
    Vernet, R.
    Belkouch, M. -C.
    Luy, P.
    Ancrenaz, V.
    Py, C.
    Grogg, J.
    Harboe-Schmidt, P.
    Bouche, N.
    ANNALS OF ONCOLOGY, 2015, 26 : 2 - 2
  • [6] Editorial: Cell Transplantation in Diabetes: Cell-Based Immunotherapy for Type 1 Diabetes
    Wei, Lingling
    Yamada, Kazuhiko
    Wang, Ping
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [7] Cell-based immunotherapy successfully treated type 1 diabetes in mice
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (01) : 9 - 10
  • [8] Dendritic cell-based cancer immunotherapy targeting MUC-1
    Wierecky, J
    Mueller, M
    Brossart, P
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (01) : 63 - 67
  • [9] Dendritic cell-based cancer immunotherapy targeting MUC-1
    J. Wierecky
    M. Mueller
    P. Brossart
    Cancer Immunology, Immunotherapy, 2006, 55 : 63 - 67
  • [10] The Role of Beta Cell Antigen Presentation in Dendritic Cell-Based Type 1 Diabetes Immunotherapy
    Xia, Chang-Qing
    Qiu, Yushi
    Peng, Ruihua
    Lo-Dauer, Jeannette
    Clare-Salzler, Michael J.
    JOURNAL OF IMMUNOLOGY, 2007, 178
12345